SLC29A1
Equilibrative nucleoside transporter 1
As of the edition of 20 October 2026, SLC29A1 (equilibrative nucleoside transporter 1, UniProt Q99808) has 2 drugs tested at it and 2 companies on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- Q99808
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Solved structures
- 3
- Disease areas
- Heart and blood vessels; Nervous system; Immune system; Urinary and reproductive; Pregnancy and women's health; Skin and connective tissue; Bones, joints and muscles; Infections
- Registered trials of its drugs
- 46
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 1 |
| Status not established | 1 |
| Total | 2 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Dipyridamole | Marketed | Phase 4 | none listed |
| EOS301984 | Status not established | Phase 1 | none listed |
2 of 2 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 2 |
| Total on the list | 2 |